Patient no. | Sex | Age (y) | Weight (kg) | Primary tumor | cTNM | pTNM |
---|---|---|---|---|---|---|
1 | F | 57 | 68 | Oral cavity, tongue, right | T2N0M0 | T2N1M0 |
2 | M | 57 | 82 | Oropharynx, base of tongue, right | TXN2aM0 | T1N2bM0 |
3 | F | 72 | 71 | Oropharynx, tonsil, right | T2N2bM0 | T2N2bM0 |
4 | F | 53 | 81 | Oropharynx, tonsil, right | T3N0M0 | T3N2bM0 |
5 | M | 63 | 78 | Oropharynx, tonsil, right | T4N0M0 | T4N2bM0 |
6 | F | 58 | 62 | Oral cavity, floor of mouth, left | T4N0M0 | T4N2bM0 |
7 | M | 54 | 67 | Oral cavity, tongue, right | T3N0M0 | T3N2bM0 |
8 | M | 55 | 72 | Oropharynx, tonsil, left | T4N2aM0 | T4N2bM0 |
9 | F | 54 | 82 | Hypopharynx, piriform sinus, left | T4N2bM0 | T4N2bM0 |
10 | F | 65 | 67 | Oral cavity, base of tongue, right | T2N0M0 | T2N0M0 |
11 | M | 53 | 90 | Larynx, glottic | T4N0M0 | T4N0M0 |
12 | M | 59 | 75 | Larynx, supraglottic | T4N0M0 | T4N0M0 |
13 | F | 49 | 49 | Residual disease of T2N0 tonsil carcinoma, left | NA | NA |
14 | M | 58 | 100 | Oropharynx, base of tongue, right | T2N2bM0 | T2N2bM0 |
15 | M | 48 | 115 | Oropharynx, tonsil, right | T3N0M0 | T3N1M0 |
16 | F | 63 | 67 | Oropharynx, tonsil, left | T3N2bM0 | T3N2cM0 |
17 | M | 53 | 104 | Oropharynx, tonsil, right | T2N3M0 | T2N3M0 |
19 | M | 71 | 87 | Oropharynx, soft palate, right | T3N2cM0 | T2N2cM0 |
20 | M | 60 | 58 | Larynx, supraglottic, recurrence | NA | NA |
For patient 18, not enough data were available for adequate dosimetric analysis. NA = not applicable.